Inter-laboratory variability of A549 epithelial cells grown under submerged and air-liquid interface conditions.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 02 12 2020
revised: 26 03 2021
accepted: 22 04 2021
pubmed: 28 4 2021
medline: 8 1 2022
entrez: 27 4 2021
Statut: ppublish

Résumé

In vitro cell models offer a unique opportunity for conducting toxicology research, and the human lung adenocarcinoma cell line A549 is commonly used for toxicology testing strategies. It is essential to determine whether the response of these cells grown in different laboratories is consistent. In this study, A549 cells were grown under both submerged and air-liquid interface (ALI) conditions following an identical cell seeding protocol in two independent laboratories. The cells were switched to the ALI after four days of submerged growth, and their behaviour was compared to submerged conditions. The membrane integrity, cell viability, morphology, and (pro-)inflammatory response upon positive control stimuli were assessed at days 3, 5, and 7 under submerged conditions and at days 5, 7, and 10 at the ALI. Due to the high variability of the results between the two laboratories, the experiment was subsequently repeated using identical reagents at one specific time point and condition (day 5 at the ALI). Despite some variability, the results were more comparable, proving that the original protocol necessitated improvements. In conclusion, the use of detailed protocols and consumables from the same providers, special training of personnel for cell handling, and endpoint analysis are critical to obtain reproducible results across independent laboratories.

Identifiants

pubmed: 33905840
pii: S0887-2333(21)00103-X
doi: 10.1016/j.tiv.2021.105178
pii:
doi:

Substances chimiques

CXCL8 protein, human 0
IL6 protein, human 0
Interleukin-6 0
Interleukin-8 0
Lipopolysaccharides 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105178

Informations de copyright

Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved.

Auteurs

Hana Barosova (H)

BioNanomaterials Group, Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland; Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, Czech Republic.

Kirsty Meldrum (K)

In Vitro Toxicology Group, Swansea University Medical School, Swansea University, SA2 8PP, Wales, United Kingdom.

Bedia Begum Karakocak (BB)

BioNanomaterials Group, Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland.

Sandor Balog (S)

BioNanomaterials Group, Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland.

Shareen H Doak (SH)

In Vitro Toxicology Group, Swansea University Medical School, Swansea University, SA2 8PP, Wales, United Kingdom.

Alke Petri-Fink (A)

BioNanomaterials Group, Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland.

Martin J D Clift (MJD)

In Vitro Toxicology Group, Swansea University Medical School, Swansea University, SA2 8PP, Wales, United Kingdom. Electronic address: m.j.d.clift@swansea.ac.uk.

Barbara Rothen-Rutishauser (B)

BioNanomaterials Group, Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland. Electronic address: barbara.rothen@unifr.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH